Pharmaceutical Technology Europe-01-01-2010

Pharmaceutical Technology Europe

A new generation of transdermal delivery

January 01, 2010

Special Feature

22

1

Transdermal drug delivery is valued by patients and physicians for the comfort and convenience it offers — no needles, no pills and ease of use

Can you predict 2010

January 01, 2010

22

1

As with most others, the pharmaceutical industry is entering 2010 with trepidation; will this year bring a similar number of headline grabbing announcements of mergers and acquisitions, plant closures, job cuts, restructuring, etc.

The year ahead

January 01, 2010

Outsourcing Review

22

1

It's customary among columnists to begin a new year with some predictions about what's to come. We don't honour that custom every year, but with what the contract services industry went through in 2009, it seemed appropriate to share thoughts on what we expect for 2010.

Another twist in the EU parallel trade saga?

January 01, 2010

Spotlight

22

1

The free movement of goods across Europe might be beneficial for some, but for pharmaceutical companies, the parallel trade of medicines is not welcomed, and is viewed as a system that can damage patient safety and innovation

Developing a vaccine that is stable at room temperature for 8 weeks

January 01, 2010

Special Feature

22

1

There is a pressing need to improve the storage stability of currently available vaccines, and achieving this could facilitate mass vaccination campaigns and increase vaccination coverage on a global scale — particularly to underserved and remote regions of the world.

Tumour-penetrating microparticles

January 01, 2010

Special Feature

22

1

Tumour-penetrating microparticles (TPM), drug delivery vehicles that have been designed to specifically target and infiltrate peritoneal tumours, are more efficacious than standard chemotherapy, according to our preliminary research data.